Keep up with our core and affiliated faculty in the national and international news. Read their op-ed pieces, quotes and interviews, and cutting-edge research findings.
In order to succeed, you need to be able to tell a good story.
Five years after sharing the 2012 Nobel Prize in Chemistry with his former student, Stanford’s Brian Kobilka, Robert Lefkowitz of the Duke University Medical Center continues lab work. At age 75, he’s still building on the groundbreaking discoveries that reveal the functions of G protein-coupled receptors which drive the effects of half of all medications. He also contemplates issues as timeless and conventional as the importance of mentors and as topical and controversial as the danger of the anti-science attitudes of the current presidential administration. At the fifth anniversary of his becoming a Nobel laureate, Lefkowitz sat with Emilia Chiscop-Head, an internationally awarded journalist now working at Duke University Initiative for Science & Society, for a wide-ranging discussion.
Read the full interview on Duke Today.
Scientists at Duke University have identified a neuron that acts as the “master controller” of habits. The findings, published in the journal eLife, could someday change the ways addiction and compulsive behavior are treated.
Nothing goes together like professional football and genetic testing, amiright?
That’s what the Baltimore Ravens and Orig3n, a Boston direct-to-consumer genetic testing company, apparently thought when they came up with the idea for “DNA Day” at the team’s M&T Bank Stadium.
The plan was to provide free genetic test kits, emblazoned with the Ravens logo, to fans at this past Sunday’s game against the Cleveland Browns. Interested folks could swab some cells off the inside of their cheek and hand them off at the stadium. Orig3n (and no, that is not a typo) would then analyze four genes in those cells. Easy peasy.
But shoot, DNA Day was postponed at the last minute. The Baltimore Sun reported Monday that both federal and state agencies had raised questions about the promotion.
In civil aviation, automation has reduced workload and stress for pilots, while making flying one of the safest ways to travel. Can these safety lessons apply to autonomous cars – especially with regard to how we as drivers will interact with them? We spoke to a human factors expert to get answers.
Right now, there are two ways to be safe crossing a road: Wait until no cars are close by, so there’s enough time to make it to the other side of the street – or communicate with oncoming drivers. As the number of pedestrian deaths on U.S. roads climbs, up 25 percent since 2010 to more than 5,000 people in 2015, the dawn of driverless cars offers the promise of improving that sad safety record.
Read the full article on the Conversation